Literature DB >> 31308148

The Emerging Role of YAP/TAZ in Tumor Immunity.

Zhaoji Pan1, Yiqing Tian2, Chengsong Cao1, Guoping Niu1.   

Abstract

Yes-associated protein (YAP)/WW domain-containing transcription regulator 1 (TAZ) is an important transcriptional regulator and effector of the Hippo signaling pathway that has emerged as a critical determinant of malignancy in many human tumors. YAP/TAZ expression regulates the cross-talk between immune cells and tumor cells in the tumor microenvironment through its influence on T cells, myeloid-derived suppressor cells, and macrophages. However, the mechanisms underlying these effects are poorly understood. An improved understanding of the role of YAP/TAZ in tumor immunity is essential for exploring innovative tumor treatments and making further breakthroughs in antitumor immunotherapy. This review primarily focuses on the role of YAP/TAZ in immune cells, their interactions with tumor cells, and how this impacts on tumorigenesis, progression, and therapy resistance. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31308148     DOI: 10.1158/1541-7786.MCR-19-0375

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  25 in total

1.  Circular RNA circ-CDYL sponges miR-1180 to elevate yes-associated protein in multiple myeloma.

Authors:  Fang Chen; Xiaohui Wang; Shuang Fu; Shaokun Wang; Yu Fu; Jihong Zhang; Zhuogang Liu
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-22

2.  RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription.

Authors:  Jianjun Wang; Feng Huang; Yaxiang Shi; Qinghui Zhang; Song Xu; Yongliang Yao; Runqiu Jiang
Journal:  Gastric Cancer       Date:  2020-07-04       Impact factor: 7.370

3.  Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.

Authors:  Amelia U Schirmer; Lucy M Driver; Megan T Zhao; Carrow I Wells; Julie E Pickett; Sean N O'Bryne; Benjamin J Eduful; Xuan Yang; Lauren Howard; Sungyong You; Gayathri R Devi; John DiGiovanni; Stephen J Freedland; Jen-Tsan Chi; David H Drewry; Everardo Macias
Journal:  Mol Ther       Date:  2021-08-25       Impact factor: 11.454

4.  The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.

Authors:  Yutong Wang; Hui Nie; Huiling Li; Zhiming Liao; Xuejie Yang; Xiaoyun He; Jian Ma; Jianhua Zhou; Chunlin Ou
Journal:  Front Med (Lausanne)       Date:  2022-07-05

Review 5.  YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.

Authors:  Frank Szulzewsky; Eric C Holland; Valeri Vasioukhin
Journal:  Dev Biol       Date:  2021-01-08       Impact factor: 3.148

Review 6.  A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations.

Authors:  Hirohito Yamaguchi; Ghina M Taouk
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

7.  Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway.

Authors:  Pei San Yee; Stacey Price; Annie Wai Yeeng Chai; Shi Mun Yee; Hui Mei Lee; Vivian Kh Tiong; Emanuel Gonçalves; Fiona M Behan; Jessica Bateson; James Gilbert; Aik Choon Tan; Ultan McDermott; Mathew J Garnett; Sok Ching Cheong
Journal:  Elife       Date:  2020-09-29       Impact factor: 8.140

8.  Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer.

Authors:  Ajaratu Keshinro; Chad Vanderbilt; Jin K Kim; Canan Firat; Chin-Tung Chen; Rona Yaeger; Karuna Ganesh; Neil H Segal; Mithat Gonen; Jinru Shia; Zsofia Stadler; Martin R Weiser
Journal:  JCO Precis Oncol       Date:  2021-05-12

9.  Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy.

Authors:  Seung-Woo Baek; In-Hwan Jang; Seon-Kyu Kim; Jong-Kil Nam; Sun-Hee Leem; In-Sun Chu
Journal:  Int J Mol Sci       Date:  2020-03-08       Impact factor: 5.923

Review 10.  The Emerging Role of GC-MSCs in the Gastric Cancer Microenvironment: From Tumor to Tumor Immunity.

Authors:  Zhaoji Pan; Yiqing Tian; Guoping Niu; Chengsong Cao
Journal:  Stem Cells Int       Date:  2019-12-02       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.